Topics
- Toxicology & Safety
- Applying Predictive and Simulation Modelling in Preclinical Development
- Using Predictive Pharmaceutical Modelling to Predict a Compound’s SAR Profile
- Maximising Drug Investments
- Optimising Decision Making in Early Development- Prioritising the Best Investments
- Maximising Investment to Reduce Risk and Cost of Early Development
- Biomarkers
- Utilising Biomarkers to Bridge the Gap Between Preclinical and Clinical Trials
- Accelerating Clinical Trials Using Predictive Humanised Animal Models
Who should Attend
Directors, VPs and Heads of: Drug Development, Clinical Development, Biomarker development, Early Development, Clinical Toxicology, Head of Toxicology, Clinical Trial Management, Head of R&D, Clinical Oncology, Drug Safety Translational Research, Analytical R&D, Process Chemistry, Safety Assessment, Drug Metabolism and Pharmacokinetics (DMPK), Bioanalytical, Safety Pharmacology and Clinical Pharmacology.
